Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.
2.

The history of the psychopharmacology of schizophrenia.

Lehmann HE, Ban TA.

Can J Psychiatry. 1997 Mar;42(2):152-62.

PMID:
9067064
3.

Before they called it psychopharmacology.

Lehmann HE.

Neuropsychopharmacology. 1993 Jun;8(4):291-303. No abstract available.

4.

Clinical and pharmacological approaches to the aging brain (mind).

Lehmann HE.

Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:514A-515A. No abstract available.

PMID:
1498934
5.

Diagnosis of the dementias.

Lehmann HE.

Mod Probl Pharmacopsychiatry. 1989;23:10-20. Review. No abstract available.

PMID:
2524002
6.

An 11-year follow-up study of 110 depressed patients.

Lehmann HE, Fenton FR, Deutsch M, Feldman S, Engelsmann F.

Acta Psychiatr Scand. 1988 Jul;78(1):57-65.

PMID:
3176996
7.

The future of psychiatry: progress--mutation--or self destruct?

Lehmann HE.

Can J Psychiatry. 1986 May;31(4):362-7. No abstract available.

PMID:
3708531
8.

A call to arms for clinical research in Alzheimer's disease.

Lehmann HE.

Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):xvii-xix. No abstract available.

PMID:
3797681
9.

Depression: the evolution of modern paradigms and concepts.

Lehmann HE.

Clin Neuropharmacol. 1986;9 Suppl 4:77-9.

PMID:
3567963
10.

[A special flicker fusion frequency method for detection of the effects of gerontopharmaceuticals exemplified by the L-eburnamonine study].

Plörer S, Gerstenbrand F, Lehmann HE, Saltuari L, Stralkowski E.

Psychiatr Neurol Med Psychol (Leipz). 1985 Nov;37(11):635-42. German.

PMID:
4089045
11.

Multiple personality in a case of functional psychosis.

Ghadirian AM, Lehmann HE, Dongier M, Kolivakis T.

Compr Psychiatry. 1985 Jan-Feb;26(1):22-8. No abstract available.

PMID:
3967494
12.

Early organiform impairment test (OFIT). A new performance test for assessment of early cognitive impairment.

Amin MM, Khan P, Lehmann HE, Mirmiran J.

Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):575-8.

PMID:
3911284
13.

Psychopharmacological approaches to the organic brain syndrome.

Lehmann HE.

Compr Psychiatry. 1983 Sep-Oct;24(5):412-30. Review. No abstract available.

PMID:
6138211
14.

The clinician's view of anxiety and depression.

Lehmann HE.

J Clin Psychiatry. 1983 Aug;44(8 Pt 2):3-7.

PMID:
6874656
15.

Minimal maintenance medication: effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients.

Lehmann HE, Wilson WH, Deutsch M.

Compr Psychiatry. 1983 Jul-Aug;24(4):293-303. No abstract available.

PMID:
6136389
16.

Clinical evaluation and natural course of depression.

Lehmann HE.

J Clin Psychiatry. 1983 May;44(5 Pt 2):5-10.

PMID:
6406462
17.

[From Binet and Wundt to neuropsychological measurements and behavior scales].

Lehmann HE.

Acta Psychiatr Belg. 1983 Mar-Apr;83(2):135-46. French.

PMID:
6353866
18.

A trouble in the brain-mind: self-description of a depressive episode.

Lehmann HE.

Can J Psychiatry. 1982 Apr;27(3):216-7. No abstract available.

PMID:
7093874
19.

Affective disorders in the aged.

Lehmann HE.

Psychiatr Clin North Am. 1982 Apr;5(1):27-44. No abstract available.

PMID:
6124957
20.

Sexual behavior of the male schizophrenic: the impact of illness and medications.

Nestoros JN, Lehmann HE, Ban TA.

Arch Sex Behav. 1981 Oct;10(5):421-42. Review.

PMID:
6119066
21.

Acquired transient CNS hypersensitivity to lithium therapy.

Ghadirian AM, Lehmann HE.

Can J Psychiatry. 1980 Dec;25(8):662-5.

PMID:
6110472
22.

Is psychiatry approaching a steady state?

Lehmann HE.

Compr Psychiatry. 1980 Nov-Dec;21(6):444-9. No abstract available.

PMID:
7428349
23.

Neurological side effects of lithium: organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes.

Ghadirian AM, Lehmann HE.

Compr Psychiatry. 1980 Sep-Oct;21(5):327-35. Review. No abstract available.

PMID:
6998648
24.

The differential effects of viloxazine and imipramine on performance tests: their relationship to behavioural toxicity.

Amin MM, Khan P, Lehmann HE.

Psychopharmacol Bull. 1980 Jul;16(3):57-8. No abstract available.

PMID:
7403405
25.

A comparative study of salivation in affective disorders.

Amin M, Khan P, Lehmann HE.

Psychiatr Clin (Basel). 1980;13(2):119-24.

PMID:
7444093
26.

Neuroleptic drugs and sexual function in schizophrenia.

Nestoros JN, Lehmann HE, Ban TA.

Mod Probl Pharmacopsychiatry. 1980;15:111-30. Review. No abstract available.

PMID:
6106890
27.

Behavioural reactions to triazolam.

Barclay WR, Ayd FJ Jr, Callan JP, Curran WJ, Gardner EA, Greenblatt DJ, Ladimer I, Lapierre Y, Lehmann HE, O'Donnell TJ, van Praag HM, Shader RI.

Lancet. 1979 Nov 10;2(8150):1018. No abstract available.

PMID:
91745
28.

Yawning. A homeostatic reflex and its psychological significance.

Lehmann HE.

Bull Menninger Clin. 1979 Mar;43(2):123-6. No abstract available.

PMID:
435660
29.

Conditioning and the classification of the chronic schizophrenic patient.

Ban TA, Ananth JV, Lehmann HE.

Pavlov J Biol Sci. 1979 Jan-Mar;14(1):44-60.

PMID:
537842
30.

Negative aspects of psychotherapeutic drug treatment.

Lehmann HE.

Prog Neuropsychopharmacol. 1979;3(1-3):223-9. Review.

PMID:
401341
31.

Problems with ethical aspects of psychotropic drug use.

Lehmann HE.

Prog Neuropsychopharmacol. 1979;3(1-3):271-5.

PMID:
400983
32.

Uses and abuses of psychoactive drugs.

Ban TA, Lehmann HE.

South Med J. 1978 Oct;71(10):1287-93. No abstract available.

PMID:
30172
33.

Clinical observations with beta-endorphin injections.

Kline NS, Lehmann HE.

Psychopharmacol Bull. 1978 Jul;14(3):12-3. No abstract available.

PMID:
353868
34.

Viloxazine in the treatment of depression: psychophysical measures and clinical response.

Amin MM, Ban TA, Lehmann HE, Khan P.

Psychopharmacol Bull. 1978 Jan;14(1):33-5. No abstract available.

PMID:
625536
35.

R--806--03--01 in the treatment of depression: plasma levels and therapeutic response.

Amin MM, Ban TA, Lehmann HE, Khalid R.

Psychopharmacol Bull. 1978 Jan;14(1):31-3. No abstract available.

PMID:
625535
36.

Colloquium on clinical trials with antidepressants--behavioral, psychophysical, and pharmacokinetic measurements: Introduction.

Amin MM, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1978 Jan;14(1):31. No abstract available.

PMID:
625534
37.

Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial.

Nestoros JN, Lehmann HE, Ban TA.

Int Pharmacopsychiatry. 1978;13(3):138-50.

PMID:
355181
38.

A comparison of desipramine and amitriptyline plasma levels and therapeutic response.

Amin MM, Cooper R, Khalid R, Lehmann HE.

Psychopharmacol Bull. 1978 Jan;14(1):45-6. No abstract available.

PMID:
343151
39.

Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordings.

Amin MM, Ban TA, Lehmann HE, Marcotte E.

Psychopharmacol Bull. 1978 Jan;14(1):39-42. No abstract available.

PMID:
343149
40.

Nomifensin in the treatment of depression: a report on the Canadian part of a transcultural study.

Amin MM, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1978 Jan;14(1):35-7. No abstract available.

PMID:
343147
41.

A review of nicotinic acid, N-methylated indoleamines and schizophrenia.

Luchins D, Ban TA, Lehmann HE.

Int Pharmacopsychiatry. 1978;13(1):16-33. Review.

PMID:
342436
42.

Classification of depressive states.

Lehmann HE.

Can Psychiatr Assoc J. 1977 Nov;22(7):381-90. No abstract available.

PMID:
589552
43.

Myths, theories and treatment of schizophrenia.

Ban TA, Lehmann HE.

Dis Nerv Syst. 1977 Sep;38(9):665-71. No abstract available.

PMID:
902554
44.

Beta-endorphin--induced changes in schizophrenic and depressed patients.

Kline NS, Li CH, Lehmann HE, Lajtha A, Laski E, Cooper T.

Arch Gen Psychiatry. 1977 Sep;34(9):1111-3. No abstract available.

PMID:
901140
45.

Introduction to the colloquium on new drugs in the treatment of schizophrenia.

Amin MM, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1977 Jul;13(3):4-6. No abstract available.

PMID:
887713
46.

An uncontrolled study with thiopropazate in the treatment of persistent dyskinesia.

Ananth JV, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1977 Jul;13(3):9. No abstract available.

PMID:
329332
47.

A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.

Amin MM, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1977 Jul;13(3):20-1. No abstract available.

PMID:
329325
48.

A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.

Amin MM, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1977 Jul;13(3):15-7. No abstract available.

PMID:
329323
49.

A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients.

Pecknold JC, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1977 Jul;13(3):14-5. No abstract available.

PMID:
329322
50.

A standard-controlled clinical study with trazodone in schizophrenic patients.

Deutsch M, Ban TA, Lehmann HE.

Psychopharmacol Bull. 1977 Jul;13(3):13-4. No abstract available.

PMID:
329321

Supplemental Content

Loading ...
Support Center